Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $6.57, $0.12 better than the analyst estimate of $6.45. Revenue for the quarter came in at $12.21 billion versus the consensus estimate of $11.89 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.